This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$24.78
US$ Class I Dist
NAV per share 07.04.2020
€445.5mAUM

AUM 31.03.2020

Holdings
70.18% Active Share
As at 31.03.2020